Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Research & Development (2024 - 2025)

Historic Research & Development for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $17.8 million.

  • Pyxis Oncology's Research & Development rose 37.77% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.0 million, marking a year-over-year change of. This contributed to the annual value of $58.7 million for FY2024, which is 1847.5% up from last year.
  • Per Pyxis Oncology's latest filing, its Research & Development stood at $17.8 million for Q3 2025, which was up 37.77% from $17.1 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Research & Development ranged from a high of $17.8 million in Q3 2025 and a low of $13.0 million during Q1 2024